- Home
- INGR vs ELAN Comparison
INGR vs ELAN Comparison
Compare INGR & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGR
- ELAN
- Stock Information
- Founded
- INGR 1906
- ELAN 1954
- Country
- INGR United States
- ELAN United States
- Employees
- INGR N/A
- ELAN N/A
- Industry
- INGR Packaged Foods
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- INGR Consumer Staples
- ELAN Health Care
- Exchange
- INGR Nasdaq
- ELAN Nasdaq
- Market Cap
- INGR 8.4B
- ELAN 7.2B
- IPO Year
- INGR 1997
- ELAN 2018
- Fundamental
- Price
- INGR $135.81
- ELAN $14.85
- Analyst Decision
- INGR Hold
- ELAN Buy
- Analyst Count
- INGR 5
- ELAN 7
- Target Price
- INGR $151.40
- ELAN $15.33
- AVG Volume (30 Days)
- INGR 461.5K
- ELAN 4.8M
- Earning Date
- INGR 08-01-2025
- ELAN 08-07-2025
- Dividend Yield
- INGR 2.35%
- ELAN N/A
- EPS Growth
- INGR N/A
- ELAN N/A
- EPS
- INGR 9.47
- ELAN 0.75
- Revenue
- INGR $7,361,000,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- INGR $3.20
- ELAN $4.28
- Revenue Next Year
- INGR $2.65
- ELAN $4.67
- P/E Ratio
- INGR $14.38
- ELAN $19.83
- Revenue Growth
- INGR N/A
- ELAN 1.42
- 52 Week Low
- INGR $113.94
- ELAN $8.02
- 52 Week High
- INGR $155.44
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- INGR 45.29
- ELAN 68.77
- Support Level
- INGR $134.62
- ELAN $14.47
- Resistance Level
- INGR $137.57
- ELAN $15.15
- Average True Range (ATR)
- INGR 2.20
- ELAN 0.38
- MACD
- INGR -0.15
- ELAN 0.02
- Stochastic Oscillator
- INGR 34.81
- ELAN 89.20
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.